|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3832253A
(en)
|
1973-03-21 |
1974-08-27 |
Baxter Laboratories Inc |
Method of making an inflatable balloon catheter
|
|
US4450150A
(en)
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
DE2948884A1
(de)
|
1979-12-05 |
1981-06-11 |
Basf Ag, 6700 Ludwigshafen |
2-hydroxypropylimidazole, verfahren zu ihrer herstellung und verwendung als oelloesliche korrosionsinhibitoren
|
|
US4667014A
(en)
|
1983-03-07 |
1987-05-19 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4661450A
(en)
|
1983-05-03 |
1987-04-28 |
Molecular Genetics Research And Development Limited Partnership |
Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
|
|
CA1200416A
(en)
|
1983-05-13 |
1986-02-11 |
Societe Des Produits Nestle S.A. |
Food process
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
IN165717B
(enExample)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
FR2645866B1
(fr)
|
1989-04-17 |
1991-07-05 |
Centre Nat Rech Scient |
Nouvelles lipopolyamines, leur preparation et leur emploi
|
|
JPH04167172A
(ja)
|
1990-10-31 |
1992-06-15 |
Nec Corp |
ベクトルプロセッサ
|
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
JPH07502898A
(ja)
|
1992-01-13 |
1995-03-30 |
デューク・ユニバーシティー |
酵素ｒｎａ分子
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5283241A
(en)
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
DK148292D0
(da)
|
1992-12-09 |
1992-12-09 |
Lundbeck & Co As H |
Forbindelser
|
|
US5591737A
(en)
|
1992-12-17 |
1997-01-07 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US6096880A
(en)
|
1993-04-15 |
2000-08-01 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
|
US5434261A
(en)
|
1993-07-26 |
1995-07-18 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
|
HUT75224A
(en)
|
1993-10-19 |
1997-04-28 |
Merck & Co Inc |
Combination of bisphosphonates and growth hormone secretagogues
|
|
WO1995024207A1
(en)
|
1994-03-11 |
1995-09-14 |
Merck & Co., Inc. |
Composition for the treatment of lung disease
|
|
EP0675125A1
(en)
|
1994-03-18 |
1995-10-04 |
Kyowa Hakko Kogyo Co., Ltd. |
A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
|
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
US5656606A
(en)
|
1995-02-17 |
1997-08-12 |
Merck & Co., Inc. |
Camphor compounds promote release of growth hormone
|
|
US5747485A
(en)
|
1995-04-13 |
1998-05-05 |
Merck & Co., Inc. |
Substituted azetidiones as anti-inflammatory and antidegenerative agents
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US5744335A
(en)
|
1995-09-19 |
1998-04-28 |
Mirus Corporation |
Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
|
|
GB2308064A
(en)
|
1995-10-31 |
1997-06-18 |
Merck & Co Inc |
Treatment of congestive heart failure with a growth hormone secretagogue
|
|
US5700549A
(en)
|
1996-06-24 |
1997-12-23 |
International Business Machines Corporation |
Structure to reduce stress in multilayer ceramic substrates
|
|
GB2324726A
(en)
|
1997-05-01 |
1998-11-04 |
Merck & Co Inc |
Combination Therapy for the Treatment of Osteoporosis
|
|
EP0897908A1
(de)
|
1997-08-19 |
1999-02-24 |
Roche Diagnostics GmbH |
3-Aryl-Succinamido-Hydroxamsäuren, Prozesse zu ihrer Herstellung und diese Substanzen enthaltende Medikamente
|
|
IL135578A0
(en)
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
|
US6211174B1
(en)
|
1997-10-31 |
2001-04-03 |
Merck & Co., Inc. |
Naphtho-fused lactams promote release of growth hormone
|
|
US5948902A
(en)
|
1997-11-20 |
1999-09-07 |
South Alabama Medical Science Foundation |
Antisense oligonucleotides to human serine/threonine protein phosphatase genes
|
|
US6620597B1
(en)
|
1998-01-09 |
2003-09-16 |
University Of Utah Research Foundation |
Method for in vitro amplification of circular DNA
|
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
|
WO2001060414A2
(en)
|
2000-02-17 |
2001-08-23 |
Genzyme Corporation |
Genetic modification of the lung as a portal for gene delivery
|
|
CA2404471C
(en)
|
2000-03-28 |
2010-09-28 |
Queensland University Of Technology |
A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
US20040014194A1
(en)
|
2002-03-27 |
2004-01-22 |
Schering Corporation |
Beta-secretase crystals and methods for preparing and using the same
|
|
US7250412B2
(en)
|
2003-10-24 |
2007-07-31 |
Auspex Pharmaceuticals, Inc. |
PH sensitive prodrugs of 2,6-Diisopropylphenol
|
|
WO2005079803A1
(en)
|
2004-02-13 |
2005-09-01 |
Pfizer Products, Inc. |
Compounds for treatment of cardiovascular diseases
|
|
CA2569664C
(en)
|
2004-06-07 |
2013-07-16 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
US7786153B2
(en)
|
2005-03-02 |
2010-08-31 |
Abbott Laboratories Inc. |
Compounds that are useful for improving pharmacokinetics
|
|
WO2006138380A2
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
WO2007044627A2
(en)
|
2005-10-06 |
2007-04-19 |
Sloan Kettering Institute For Cancer Research |
Compositions and methods for delivery of interfering rna
|
|
CN101016264A
(zh)
|
2007-01-22 |
2007-08-15 |
西安新安医药科技有限公司 |
用于治疗的硝基咪唑衍生物、制备方法及用途
|
|
CA2689042A1
(en)
|
2007-02-16 |
2008-08-28 |
Merck & Co., Inc. |
Compositions and methods for potentiated activity of biologicaly active molecules
|
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
１本鎖環状ｒｎａおよびその製造方法
|
|
EP2203059A4
(en)
|
2007-09-10 |
2010-11-10 |
Merck Sharp & Dohme |
METHOD FOR TREATING UNAUTHORIZED HEAVY NEUTROPENIA
|
|
CA2740000C
(en)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
EP3269395A1
(en)
|
2008-11-07 |
2018-01-17 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
WO2010084371A1
(en)
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Novel circular interfering rna molecules
|
|
US20100305197A1
(en)
|
2009-02-05 |
2010-12-02 |
Massachusetts Institute Of Technology |
Conditionally Active Ribozymes And Uses Thereof
|
|
WO2010138659A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating brain tumors
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
WO2010138652A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating kaposi sarcoma
|
|
WO2010138695A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
US20120202801A1
(en)
|
2009-05-27 |
2012-08-09 |
Liangxian Cao |
Methods for treating breast cancer
|
|
KR101766408B1
(ko)
|
2009-06-10 |
2017-08-10 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
JP5267874B2
(ja)
|
2009-07-24 |
2013-08-21 |
ソニー株式会社 |
信号処理装置、及び、信号処理方法
|
|
KR20110095439A
(ko)
|
2010-02-19 |
2011-08-25 |
건국대학교 산학협력단 |
암모니움 이미다졸륨 염 및 이를 함유하는 염료감응 태양전지용 전해질 조성물
|
|
US20130037977A1
(en)
|
2010-04-08 |
2013-02-14 |
Paul A. Burke |
Preparation of Lipid Nanoparticles
|
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
RU2013154295A
(ru)
|
2011-06-08 |
2015-07-20 |
Шир Хьюман Дженетик Терапис, Инк. |
КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК
|
|
ES2795110T3
(es)
|
2011-06-08 |
2020-11-20 |
Translate Bio Inc |
Lípidos escindibles
|
|
WO2013012476A2
(en)
|
2011-07-21 |
2013-01-24 |
Arizona Chemical Company, Llc |
Branched polyether-polyamide block copolymers and methods of making and using the same
|
|
WO2013073480A1
(ja)
|
2011-11-18 |
2013-05-23 |
日油株式会社 |
細胞内動態を改善したカチオン性脂質
|
|
GB2496898B
(en)
|
2011-11-25 |
2020-10-28 |
Petroliam Nasional Berhad Petronas |
Corrosion inhibition
|
|
JP6284181B2
(ja)
|
2012-02-09 |
2018-02-28 |
国立研究開発法人理化学研究所 |
環状ｒｎａ及びタンパク質の製造方法
|
|
EP4331620A3
(en)
*
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
ES2859923T3
(es)
|
2013-02-28 |
2021-10-04 |
Univ Tufts |
Compuestos de disulfuro para el suministro de agentes farmacéuticos
|
|
HK1220626A1
(zh)
|
2013-03-15 |
2017-05-12 |
The Centre For Drug Research And Development |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
EP2996697B1
(en)
|
2013-05-15 |
2019-06-26 |
Robert Kruse |
Intracellular translation of circular rna
|
|
EP3017013A4
(en)
|
2013-05-28 |
2017-01-25 |
Yanjie Xu |
Refrigeration system with dual refrigerants and liquid working fluids
|
|
US8805972B1
(en)
|
2013-06-26 |
2014-08-12 |
Kaspersky Lab Zao |
Multi-platform operational objective configurator for computing devices
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3083556B1
(en)
|
2013-12-19 |
2019-12-25 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US10821175B2
(en)
|
2014-02-25 |
2020-11-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
PL4023249T3
(pl)
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
|
US11633487B2
(en)
|
2014-08-06 |
2023-04-25 |
Ascendis Pharma A/S |
Prodrugs comprising an aminoalkyl glycine linker
|
|
EP4219532A3
(en)
*
|
2015-06-05 |
2023-08-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for transient gene therapy with enhanced stability
|
|
US10501768B2
(en)
|
2015-07-13 |
2019-12-10 |
Curevac Ag |
Method of producing RNA from circular DNA and corresponding template DNA
|
|
AU2016306209B2
(en)
|
2015-08-07 |
2023-07-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific CAR T-cells for solid tumor targeting
|
|
RU2018105118A
(ru)
|
2015-08-21 |
2019-09-23 |
Пфайзер Инк. |
Терапевтические наночастицы, содержащие терапевтический агент, и способы их получения и применения
|
|
JP6685039B2
(ja)
|
2015-08-26 |
2020-04-22 |
国立大学法人東北大学 |
化合物、イオン液体、白金族元素の抽出剤、白金族元素の抽出方法
|
|
LU92830B1
(en)
|
2015-09-15 |
2017-04-03 |
Luxembourg Inst Of Health Lih |
Biomarkers for heart failure
|
|
CN105176981B
(zh)
|
2015-09-17 |
2017-03-15 |
广州永诺健康科技有限公司 |
用于环状rna表达的dna序列和表达载体及其应用
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
EP3356556B1
(en)
|
2015-09-29 |
2019-12-11 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
A method for diagnosing a disease by detection of circrna in bodily fluids
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
EP4011451A1
(en)
|
2015-10-22 |
2022-06-15 |
ModernaTX, Inc. |
Metapneumovirus mrna vaccines
|
|
HRP20230209T1
(hr)
|
2015-10-28 |
2023-04-14 |
Acuitas Therapeutics Inc. |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
WO2017118734A1
(en)
|
2016-01-08 |
2017-07-13 |
The Institute Of Cancer Research: Royal Cancer Hospital |
Inhibitors of ataxia-telangiectasia mutated and rad3-related protein kinase (atr) for use in methods of treating cancer
|
|
SI3458083T1
(sl)
|
2016-05-18 |
2023-03-31 |
Modernatx, Inc. |
Polinukleotidi, ki kodirajo interlevkin-12 (IL12) in njihova uporaba
|
|
US11001861B2
(en)
|
2016-05-18 |
2021-05-11 |
Modernatx, Inc. |
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1
|
|
IL263079B2
(en)
|
2016-05-18 |
2024-05-01 |
Modernatx Inc |
Polynucleotides encoding relaxin
|
|
US20190298657A1
(en)
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
EP3458104A1
(en)
|
2016-05-18 |
2019-03-27 |
Modernatx, Inc. |
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
|
|
WO2017201342A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding jagged1 for the treatment of alagille syndrome
|
|
US12123030B2
(en)
|
2016-05-18 |
2024-10-22 |
Modernatx, Inc. |
Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia
|
|
MA45036A
(fr)
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour la citrine pour le traitement de la citrullinémie de type 2
|
|
WO2017222911A1
(en)
|
2016-06-20 |
2017-12-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular rnas and their use in immunomodulation
|
|
US20180010175A1
(en)
|
2016-09-22 |
2018-01-11 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for cloning circular rna
|
|
CN110402145A
(zh)
|
2016-10-26 |
2019-11-01 |
莫得纳特斯公司 |
用于增强免疫应答的信使核糖核酸及其使用方法
|
|
CA3040337A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Curevac Ag |
Lipid nanoparticle mrna vaccines
|
|
US20190290694A1
(en)
|
2016-12-21 |
2019-09-26 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
|
JP6792847B2
(ja)
|
2016-12-27 |
2020-12-02 |
国立大学法人 東京大学 |
ｍＲＮＡの機能化方法
|
|
BR112019015797A2
(pt)
|
2017-02-01 |
2020-03-17 |
Modernatx, Inc. |
Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação
|
|
CN106801050B
(zh)
|
2017-02-20 |
2020-01-14 |
广州永诺生物科技有限公司 |
一种环状rna高通量测序文库的构建方法及其试剂盒
|
|
WO2018157009A1
(en)
|
2017-02-24 |
2018-08-30 |
Modernatx, Inc. |
Nucleic acid-based therapy of muscular dystrophies
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
RESPIRATORY SYNCYTIAL VIRUS Vaccine
|
|
AU2018251187B2
(en)
*
|
2017-04-14 |
2024-03-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for transient gene therapy with enhanced stability
|
|
US12123031B2
(en)
|
2017-05-31 |
2024-10-22 |
Vilnius University |
Regulation of CRISPR-associated rossman fold (CARF) domain containing proteins by oligoadenylates
|
|
WO2018237372A1
(en)
|
2017-06-23 |
2018-12-27 |
Cornell University |
RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT
|
|
SI3703658T1
(sl)
*
|
2017-10-31 |
2022-09-30 |
Astrazeneca Ab |
Lipidni nanodelci za dostavljanje spremenjene RNA, ki kodira polipeptid VEGF-A
|
|
CN111819185A
(zh)
*
|
2017-12-15 |
2020-10-23 |
旗舰创业创新第六有限责任公司 |
包含环状多核糖核苷酸的组合物及其用途
|
|
US20190314291A1
(en)
|
2018-01-30 |
2019-10-17 |
Modernatx, Inc. |
Compositions and methods for delivery of agents to immune cells
|
|
CN112055695A
(zh)
*
|
2018-05-01 |
2020-12-08 |
弗莱德哈钦森癌症研究中心 |
用于基因表达的纳米粒子和其用途
|
|
WO2019222275A2
(en)
*
|
2018-05-14 |
2019-11-21 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using inducible fusion proteins
|
|
CN112399860B
(zh)
|
2018-06-06 |
2024-08-16 |
麻省理工学院 |
用于在真核细胞中翻译的环状rna
|
|
US20210276987A1
(en)
|
2018-07-03 |
2021-09-09 |
Washington State University |
Pharmaceutical agents for use in smoking and tobacco cessation
|
|
AU2019310448A1
(en)
|
2018-07-24 |
2021-03-11 |
Mayo Foundation For Medical Education And Research |
Circularized engineered rna and methods
|
|
US20220119375A1
(en)
|
2018-08-17 |
2022-04-21 |
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. |
3-aryloxy-3-aryl-propylamine compound and uses thereof
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020198403A2
(en)
|
2019-03-25 |
2020-10-01 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising modified circular polyribonucleotides and uses thereof
|
|
BR112021023411A2
(pt)
|
2019-05-22 |
2022-02-01 |
Massachusetts Inst Technology |
Composições e métodos de rna circular
|
|
JP2022537154A
(ja)
|
2019-06-14 |
2022-08-24 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
細胞治療のための環状ｒｎａ
|
|
US20220288176A1
(en)
|
2019-08-28 |
2022-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular rna modification and methods of use
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
US20230000773A1
(en)
|
2019-09-19 |
2023-01-05 |
Modernatx, Inc. |
Novel headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
EP3819377A1
(en)
|
2019-11-08 |
2021-05-12 |
Justus-Liebig-Universität Gießen |
Circular rna and uses thereof for inhibiting rna-binding proteins
|
|
CN121422256A
(zh)
|
2019-12-04 |
2026-01-30 |
奥纳治疗公司 |
环状rna组合物和方法
|